2016 American Transplant Congress
Center Level Analysis of Changes in Living Donor Transplant Rates in the United States.
Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA.
Rates of living donor kidney transplantation have been declining in the United States since 2003. Tremendous variation exists in the rate of living donor transplantation…2016 American Transplant Congress
Late Renal Xenograft Failure Is Antibody-Mediated: Description of the Longest-Reported Survival in Pig-to-Primate Renal Xenotransplantation.
Introduction. Xenotransplantation has the potential to alleviate the organ supply shortage, yet pig-to-primate renal xenotransplant has met limited success due to natural preformed anti-pig antibody.…2016 American Transplant Congress
The Effect of Rituximab on Hepatitis B Reactivation in Kidney Transplant Recipients with Resolved Hepatitis B.
Background: Hepatitis B virus (HBV) reactivation is a well-known complication of immunosuppressive therapy in resolved HBV (hepatitis B surface antigen [HBsAg] negative and hepatitis B…2016 American Transplant Congress
Living Donor Rates Vary Greatly Among Organ Procurement Organizations in the United States.
Medicine, University of Virginia, Charlottesville, VA.
Introduction: Living donor kidney transplant remains the optimal renal replacement therapy in ESRD. Despite known benefits of living donation (LD), rates vary significantly among organ…2016 American Transplant Congress
Clinical Outcome in Pure T-Cell Mediated Acute Rejection of the Kidney with No Donor Specific Antibody or C4d Staining.
Background: T-cell mediated rejection (TCMR) is now considered to have little impact on renal graft function. This study re-evaluated the histologic phenotypes and clinical significance…2016 American Transplant Congress
Long Term Outcome of Kidney Transplant Recipients Treated with Everolimus: Final 5-Years Results from the Certic Observational Study.
Everolimus is associated with long-term benefits, such as preserving renal function and reducing the incidence of infections, malignancies and major cardiovascular events (MACE). The Certic…2016 American Transplant Congress
Outcomes of Super Obese Patients Undergoing Kidney Transplantation: A Propensity Match Analysis from the UNOS Dataset.
Surgery, University of Kentucky, Lexington.
Background: We evaluate outcomes of super obese patients (BMI>50) undergoing kidney transplantation in the US. Method: We performed a review of 190 super obese patients…2016 American Transplant Congress
Identification of Biomarkers for Progressive Fibrosis in Renal Transplant Patients Using Novel Chemical Imaging Approaches.
BackgroundThe main treatment for end-stage renal disease is kidney transplantation, however close monitoring of post-transplant biopsies is required to identify subclinical complications. In this study,…2016 American Transplant Congress
Neighborhood Socioeconomic Characteristics Influence Access to Kidney Transplantation Independently of Individual Socioeconomic Status.
Surgery, Massachusetts General Hospital, Boston, MA.
INTRODUCTION: Ensuring fair and equitable access to kidney transplantation (ATT) is of paramount importance. Socioeconomic disadvantage is associated with worse access to healthcare. Understanding the…2016 American Transplant Congress
Impact on Wound Healing Events After Early Conversion to Everolimus in De Novo Renal Transplant Recipients: 24-Month Results from the Randomized ELEVATE Study.
BackgroundWound healing events (WHE) are probably the most common type of post-transplant (Tx) surgical complication. Due to its antiproliferative properties, mammalian target of rapamycin inhibitors…
- « Previous Page
- 1
- …
- 402
- 403
- 404
- 405
- 406
- …
- 531
- Next Page »